Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment

This article provides billing and coding guidance that complements the Local Coverage Determination MolDX: Biomarkers in Cardiovascular Risk Assessment (LCD L36358). It does not itself state clinical coverage criteria, limits, or frequency rules; coverage decisions and required documentation should follow LCD L36358. Manual review of the referenced LCD is required to extract specific indications, limitations, documentation, and frequency rules.

"This billing and coding article does not itself define medical necessity, limitations, or exclusions; refer to MolDX: Biomarkers in Cardiovascular Risk Assessment LCD L36358 for coverage determinat..."

Sign up to see full coverage criteria, indications, and limitations.